Global Synthetic Biology Market

Synthetic Biology Market Size, Share, Growth Analysis, By Tool (Oligonucleotides and Synthetic DNA, Enzymes), By Application (Medical Application, Pharmaceuticals, Drug Discovery and Therapeutics), By Technology (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics), By Region - Industry Forecast 2026-2033

Report ID: SQMIG35H2209 | Region: Global | Published Date: December, 2025
Pages: 165 |Tables: 132 |Figures: 81

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Synthetic Biology Market size was valued at USD 17.8 Billion in 2024 and is poised to grow from USD 22.34 Billion in 2025 to USD 137.47 Billion by 2033, growing at a CAGR of 25.5% during the forecast period (2026–2033).

    The synthetic biology market providers need to focus on maximizing their business scope by reaching into new markets and developing synthetic biology for different industrial and personal uses. Raising new capital to fund their R&D and business expansion efforts will be essential for new synthetic biology companies going forward. The development of custom robots for specific applications across different industry verticals will also help companies expand their sales potential in the future. 'Genentech Inc. (U.S.)  ', 'Sorenson Genomics, LLC (U.S.)  ', 'Abbott Molecular (U.S.)  ', 'Bayer Diagnostics (U.S.)  ', 'Genomic Health (U.S.)  ', 'Thermo Fisher Scientific Inc. (US)  ', 'Merck KGaA (Germany)  ', 'Agilent Technologies (US)  ', 'Novozymes (Denmark)  ', 'Ginkgo Bioworks (US)  ', 'Amyris (US)  ', 'Precigen, Inc. (US)  ', 'GenScript (China)  ', 'Twist Bioscience (US)  ', 'Synthetic Genomics (US)  ', 'Codexis, Inc. (US)  ', 'Synthego (US)  ', 'Creative Enzymes (US)  ', 'Eurofins Scientific (Luxembourg)  ', 'Bota Biosciences Inc. (China)  ', 'Creative Biogene (US)  ', 'Enbiotix, Inc. (US)  ', 'Illumina, Inc. (US)  ', 'New England Biolabs (US)  ', 'Pareto Bio, Inc. (US) '

    Synthetic biology is improving the emergence of novel therapies, diagnostics, and vaccines, impacting the surging use in healthcare and pharmaceutical sectors. Furthermore, the said technology is used in the development of genetically tailored crops with improved resistance to diseases and pests, which aids agriculture productivity and food security. These factors are impressively helping the growth of the synthetic biology market. 

    Engineered gene’s expression is dictated by complex & dynamic epigenetics and DNA sequence. This over-activates synthetic constructs, resulting in inconsistent outcomes. Owing to this feature, the newbies in the market are bringing innovations in epigenetics technologies to navigate and handle these intricacies. 

    Geographically, the synthetic biology market is leading in North America owing to several factors like robust research and development architecture. Mainly, Canada and the United States holds a strong infrastructure for research and development. This comprises top-class universities, research institutes, and biotech companies that fuel inventions and advances in the domain of synthetic biology. Moreover, growing funding and heavy investments in synthetic biology and biotechnology from both public and private sectors aid better research and development of technologies in the region. The leading vendors operating in North America include Thermo Fisher Scientific, Agilent Technologies, Ginkgo Bioworks, and Amyris, Inc. among others. 

    Related Reports

    Computational Biology Market
    Buy Now GET FREE SAMPLE
    Gene Synthesis Market
    Buy Now GET FREE SAMPLE
    Synthetic Fuel Market
    Buy Now GET FREE SAMPLE
    Protein Engineering Market
    Buy Now GET FREE SAMPLE
    Biotech Ingredients Market
    Buy Now GET FREE SAMPLE
    DNA Synthesis Market
    Buy Now GET FREE SAMPLE
    Gene Editing Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Synthetic Biology Market

    Report ID: SQMIG35H2209

    $5,300
    BUY NOW